aluates Reports

$ 0.0

Automative

Global Urinary Antispasodics Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-11M13290

Global Urinary Antispasodics Market Research Report 2023

BUY CHAPTERS

Global Urinary Antispasodics Market Research Report 2024

Code: QYRE-Auto-11M13290

Report

August 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Piramal Pharma Solutions

Astellas

Rising Pharmaceuticals

Otto Brandes GmbH

Recordati

Antares Pharma

Accord Healthcare

Heritage Pharmaceuticals

Lannett

Leading Pharma

Major® Pharmaceuticals

Eywa Pharma

Urinary Antispasodics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Urinary Antispasodics Market

The global Urinary Antispasodics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Urinary Antispasodics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Antispasodics.

Report Scope

The Urinary Antispasodics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urinary Antispasodics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urinary Antispasodics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Urinary Antispasodics Market Report

Report Metric	Details
Report Name	Urinary Antispasodics Market
CAGR	5%
Segment by Type	10 mg 20 mg 30 mg Others
Segment by Application	Men Women
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Piramal Pharma Solutions, Allergan, Astellas, Eywa Pharma, Rising Pharmaceuticals, Otto Brandes GmbH, Recordati, Antares Pharma, Accord Healthcare, Heritage Pharmaceuticals, Lannett, Leading Pharma, Major Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urinary Antispasodics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urinary Antispasodics Market report?

Ans: The main players in the Urinary Antispasodics Market are Pfizer, Piramal Pharma Solutions, Allergan, Astellas, Eywa Pharma, Rising Pharmaceuticals, Otto Brandes GmbH, Recordati, Antares Pharma, Accord Healthcare, Heritage Pharmaceuticals, Lannett, Leading Pharma, Major Pharmaceuticals

What are the Application segmentation covered in the Urinary Antispasodics Market report?

Ans: The Applications covered in the Urinary Antispasodics Market report are Men, Women

What are the Type segmentation covered in the Urinary Antispasodics Market report?

Ans: The Types covered in the Urinary Antispasodics Market report are 10 mg, 20 mg, 30 mg, Others

Recommended Reports

Urinary & Renal Therapies

Antispasmodic & Related Drugs

Bladder & Prostate Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Urinary Antispasodics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 10 mg

1.2.3 20 mg

1.2.4 30 mg

1.2.5 Others

1.3 Market by Application

1.3.1 Global Urinary Antispasodics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Men

1.3.3 Women

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Urinary Antispasodics Market Perspective (2019-2030)

2.2 Urinary Antispasodics Growth Trends by Region

2.2.1 Global Urinary Antispasodics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Urinary Antispasodics Historic Market Size by Region (2019-2024)

2.2.3 Urinary Antispasodics Forecasted Market Size by Region (2025-2030)

2.3 Urinary Antispasodics Market Dynamics

2.3.1 Urinary Antispasodics Industry Trends

2.3.2 Urinary Antispasodics Market Drivers

2.3.3 Urinary Antispasodics Market Challenges

2.3.4 Urinary Antispasodics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Urinary Antispasodics Players by Revenue

3.1.1 Global Top Urinary Antispasodics Players by Revenue (2019-2024)

3.1.2 Global Urinary Antispasodics Revenue Market Share by Players (2019-2024)

3.2 Global Urinary Antispasodics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Urinary Antispasodics Revenue

3.4 Global Urinary Antispasodics Market Concentration Ratio

3.4.1 Global Urinary Antispasodics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Urinary Antispasodics Revenue in 2023

3.5 Urinary Antispasodics Key Players Head office and Area Served

3.6 Key Players Urinary Antispasodics Product Solution and Service

3.7 Date of Enter into Urinary Antispasodics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Urinary Antispasodics Breakdown Data by Type

4.1 Global Urinary Antispasodics Historic Market Size by Type (2019-2024)

4.2 Global Urinary Antispasodics Forecasted Market Size by Type (2025-2030)

5 Urinary Antispasodics Breakdown Data by Application

5.1 Global Urinary Antispasodics Historic Market Size by Application (2019-2024)

5.2 Global Urinary Antispasodics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Urinary Antispasodics Market Size (2019-2030)

6.2 North America Urinary Antispasodics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Urinary Antispasodics Market Size by Country (2019-2024)

6.4 North America Urinary Antispasodics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Urinary Antispasodics Market Size (2019-2030)

7.2 Europe Urinary Antispasodics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Urinary Antispasodics Market Size by Country (2019-2024)

7.4 Europe Urinary Antispasodics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Urinary Antispasodics Market Size (2019-2030)

8.2 Asia-Pacific Urinary Antispasodics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Urinary Antispasodics Market Size by Region (2019-2024)

8.4 Asia-Pacific Urinary Antispasodics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Urinary Antispasodics Market Size (2019-2030)

9.2 Latin America Urinary Antispasodics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Urinary Antispasodics Market Size by Country (2019-2024)

9.4 Latin America Urinary Antispasodics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Urinary Antispasodics Market Size (2019-2030)

10.2 Middle East & Africa Urinary Antispasodics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Urinary Antispasodics Market Size by Country (2019-2024)

10.4 Middle East & Africa Urinary Antispasodics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Urinary Antispasodics Introduction

11.1.4 Pfizer Revenue in Urinary Antispasodics Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Piramal Pharma Solutions

11.2.1 Piramal Pharma Solutions Company Detail

11.2.2 Piramal Pharma Solutions Business Overview

11.2.3 Piramal Pharma Solutions Urinary Antispasodics Introduction

11.2.4 Piramal Pharma Solutions Revenue in Urinary Antispasodics Business (2019-2024)

11.2.5 Piramal Pharma Solutions Recent Development

11.3 Allergan

11.3.1 Allergan Company Detail

11.3.2 Allergan Business Overview

11.3.3 Allergan Urinary Antispasodics Introduction

11.3.4 Allergan Revenue in Urinary Antispasodics Business (2019-2024)

11.3.5 Allergan Recent Development

11.4 Astellas

11.4.1 Astellas Company Detail

11.4.2 Astellas Business Overview

11.4.3 Astellas Urinary Antispasodics Introduction

11.4.4 Astellas Revenue in Urinary Antispasodics Business (2019-2024)

11.4.5 Astellas Recent Development

11.5 Eywa Pharma

11.5.1 Eywa Pharma Company Detail

11.5.2 Eywa Pharma Business Overview

11.5.3 Eywa Pharma Urinary Antispasodics Introduction

11.5.4 Eywa Pharma Revenue in Urinary Antispasodics Business (2019-2024)

11.5.5 Eywa Pharma Recent Development

11.6 Rising Pharmaceuticals

11.6.1 Rising Pharmaceuticals Company Detail

11.6.2 Rising Pharmaceuticals Business Overview

11.6.3 Rising Pharmaceuticals Urinary Antispasodics Introduction

11.6.4 Rising Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024)

11.6.5 Rising Pharmaceuticals Recent Development

11.7 Otto Brandes GmbH

11.7.1 Otto Brandes GmbH Company Detail

11.7.2 Otto Brandes GmbH Business Overview

11.7.3 Otto Brandes GmbH Urinary Antispasodics Introduction

11.7.4 Otto Brandes GmbH Revenue in Urinary Antispasodics Business (2019-2024)

11.7.5 Otto Brandes GmbH Recent Development

11.8 Recordati

11.8.1 Recordati Company Detail

11.8.2 Recordati Business Overview

11.8.3 Recordati Urinary Antispasodics Introduction

11.8.4 Recordati Revenue in Urinary Antispasodics Business (2019-2024)

11.8.5 Recordati Recent Development

11.9 Antares Pharma

11.9.1 Antares Pharma Company Detail

11.9.2 Antares Pharma Business Overview

11.9.3 Antares Pharma Urinary Antispasodics Introduction

11.9.4 Antares Pharma Revenue in Urinary Antispasodics Business (2019-2024)

11.9.5 Antares Pharma Recent Development

11.10 Accord Healthcare

11.10.1 Accord Healthcare Company Detail

11.10.2 Accord Healthcare Business Overview

11.10.3 Accord Healthcare Urinary Antispasodics Introduction

11.10.4 Accord Healthcare Revenue in Urinary Antispasodics Business (2019-2024)

11.10.5 Accord Healthcare Recent Development

11.11 Heritage Pharmaceuticals

11.11.1 Heritage Pharmaceuticals Company Detail

11.11.2 Heritage Pharmaceuticals Business Overview

11.11.3 Heritage Pharmaceuticals Urinary Antispasodics Introduction

11.11.4 Heritage Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024)

11.11.5 Heritage Pharmaceuticals Recent Development

11.12 Lannett

11.12.1 Lannett Company Detail

11.12.2 Lannett Business Overview

11.12.3 Lannett Urinary Antispasodics Introduction

11.12.4 Lannett Revenue in Urinary Antispasodics Business (2019-2024)

11.12.5 Lannett Recent Development

11.13 Leading Pharma

11.13.1 Leading Pharma Company Detail

11.13.2 Leading Pharma Business Overview

11.13.3 Leading Pharma Urinary Antispasodics Introduction

11.13.4 Leading Pharma Revenue in Urinary Antispasodics Business (2019-2024)

11.13.5 Leading Pharma Recent Development

11.14 Major Pharmaceuticals

11.14.1 Major Pharmaceuticals Company Detail

11.14.2 Major Pharmaceuticals Business Overview

11.14.3 Major Pharmaceuticals Urinary Antispasodics Introduction

11.14.4 Major Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024)

11.14.5 Major Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Piramal Pharma Solutions

Astellas

Rising Pharmaceuticals

Otto Brandes GmbH

Recordati

Antares Pharma

Accord Healthcare

Heritage Pharmaceuticals

Lannett

Leading Pharma

Major® Pharmaceuticals

Eywa Pharma

List of Tables

Table 1. Global Urinary Antispasodics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of 10 mg

Table 3. Key Players of 20 mg

Table 4. Key Players of 30 mg

Table 5. Key Players of Others

Table 6. Global Urinary Antispasodics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Urinary Antispasodics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Urinary Antispasodics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Urinary Antispasodics Market Share by Region (2019-2024)

Table 10. Global Urinary Antispasodics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Urinary Antispasodics Market Share by Region (2025-2030)

Table 12. Urinary Antispasodics Market Trends

Table 13. Urinary Antispasodics Market Drivers

Table 14. Urinary Antispasodics Market Challenges

Table 15. Urinary Antispasodics Market Restraints

Table 16. Global Urinary Antispasodics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Urinary Antispasodics Market Share by Players (2019-2024)

Table 18. Global Top Urinary Antispasodics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Antispasodics as of 2023)

Table 19. Ranking of Global Top Urinary Antispasodics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Urinary Antispasodics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Urinary Antispasodics Product Solution and Service

Table 23. Date of Enter into Urinary Antispasodics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Urinary Antispasodics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Urinary Antispasodics Revenue Market Share by Type (2019-2024)

Table 27. Global Urinary Antispasodics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Urinary Antispasodics Revenue Market Share by Type (2025-2030)

Table 29. Global Urinary Antispasodics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Urinary Antispasodics Revenue Market Share by Application (2019-2024)

Table 31. Global Urinary Antispasodics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Urinary Antispasodics Revenue Market Share by Application (2025-2030)

Table 33. North America Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Urinary Antispasodics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Urinary Antispasodics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Urinary Antispasodics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Urinary Antispasodics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Urinary Antispasodics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Urinary Antispasodics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Urinary Antispasodics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Urinary Antispasodics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Urinary Antispasodics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Urinary Antispasodics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Urinary Antispasodics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Pfizer Company Detail

Table 49. Pfizer Business Overview

Table 50. Pfizer Urinary Antispasodics Product

Table 51. Pfizer Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Piramal Pharma Solutions Company Detail

Table 54. Piramal Pharma Solutions Business Overview

Table 55. Piramal Pharma Solutions Urinary Antispasodics Product

Table 56. Piramal Pharma Solutions Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 57. Piramal Pharma Solutions Recent Development

Table 58. Allergan Company Detail

Table 59. Allergan Business Overview

Table 60. Allergan Urinary Antispasodics Product

Table 61. Allergan Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 62. Allergan Recent Development

Table 63. Astellas Company Detail

Table 64. Astellas Business Overview

Table 65. Astellas Urinary Antispasodics Product

Table 66. Astellas Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 67. Astellas Recent Development

Table 68. Eywa Pharma Company Detail

Table 69. Eywa Pharma Business Overview

Table 70. Eywa Pharma Urinary Antispasodics Product

Table 71. Eywa Pharma Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 72. Eywa Pharma Recent Development

Table 73. Rising Pharmaceuticals Company Detail

Table 74. Rising Pharmaceuticals Business Overview

Table 75. Rising Pharmaceuticals Urinary Antispasodics Product

Table 76. Rising Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 77. Rising Pharmaceuticals Recent Development

Table 78. Otto Brandes GmbH Company Detail

Table 79. Otto Brandes GmbH Business Overview

Table 80. Otto Brandes GmbH Urinary Antispasodics Product

Table 81. Otto Brandes GmbH Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 82. Otto Brandes GmbH Recent Development

Table 83. Recordati Company Detail

Table 84. Recordati Business Overview

Table 85. Recordati Urinary Antispasodics Product

Table 86. Recordati Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 87. Recordati Recent Development

Table 88. Antares Pharma Company Detail

Table 89. Antares Pharma Business Overview

Table 90. Antares Pharma Urinary Antispasodics Product

Table 91. Antares Pharma Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 92. Antares Pharma Recent Development

Table 93. Accord Healthcare Company Detail

Table 94. Accord Healthcare Business Overview

Table 95. Accord Healthcare Urinary Antispasodics Product

Table 96. Accord Healthcare Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 97. Accord Healthcare Recent Development

Table 98. Heritage Pharmaceuticals Company Detail

Table 99. Heritage Pharmaceuticals Business Overview

Table 100. Heritage Pharmaceuticals Urinary Antispasodics Product

Table 101. Heritage Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 102. Heritage Pharmaceuticals Recent Development

Table 103. Lannett Company Detail

Table 104. Lannett Business Overview

Table 105. Lannett Urinary Antispasodics Product

Table 106. Lannett Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 107. Lannett Recent Development

Table 108. Leading Pharma Company Detail

Table 109. Leading Pharma Business Overview

Table 110. Leading Pharma Urinary Antispasodics Product

Table 111. Leading Pharma Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 112. Leading Pharma Recent Development

Table 113. Major Pharmaceuticals Company Detail

Table 114. Major Pharmaceuticals Business Overview

Table 115. Major Pharmaceuticals Urinary Antispasodics Product

Table 116. Major Pharmaceuticals Revenue in Urinary Antispasodics Business (2019-2024) & (US$ Million)

Table 117. Major Pharmaceuticals Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Urinary Antispasodics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Urinary Antispasodics Market Share by Type: 2023 VS 2030

Figure 3. 10 mg Features

Figure 4. 20 mg Features

Figure 5. 30 mg Features

Figure 6. Others Features

Figure 7. Global Urinary Antispasodics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Urinary Antispasodics Market Share by Application: 2023 VS 2030

Figure 9. Men Case Studies

Figure 10. Women Case Studies

Figure 11. Urinary Antispasodics Report Years Considered

Figure 12. Global Urinary Antispasodics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Urinary Antispasodics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Urinary Antispasodics Market Share by Region: 2023 VS 2030

Figure 15. Global Urinary Antispasodics Market Share by Players in 2023

Figure 16. Global Top Urinary Antispasodics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Antispasodics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Urinary Antispasodics Revenue in 2023

Figure 18. North America Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Urinary Antispasodics Market Share by Country (2019-2030)

Figure 20. United States Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Urinary Antispasodics Market Share by Country (2019-2030)

Figure 24. Germany Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Urinary Antispasodics Market Share by Region (2019-2030)

Figure 32. China Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Urinary Antispasodics Market Share by Country (2019-2030)

Figure 40. Mexico Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Urinary Antispasodics Market Share by Country (2019-2030)

Figure 44. Turkey Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Urinary Antispasodics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 47. Piramal Pharma Solutions Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 48. Allergan Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 49. Astellas Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 50. Eywa Pharma Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 51. Rising Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 52. Otto Brandes GmbH Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 53. Recordati Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 54. Antares Pharma Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 55. Accord Healthcare Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 56. Heritage Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 57. Lannett Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 58. Leading Pharma Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 59. Major Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Tract Infection Therapeutics Market Research Report 2025

Global Urinary Incontinence Drug Market Research Report 2025

Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Tract Infection UTI Medications Market Research Report 2025

Medicine Treat BPH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Overactive Bladder Drug Market Research Report 2024

Global Urinary Tract Cancer Treatment Market Research Report 2024

Global Bladder Diseases Drug Market Research Report 2025

Global Overactive Bladder OAB Bionic Drug Market Research Report 2025

Global Genitourinary System Treatment Market Research Report 2024

Global Female Urinary Incontinence Treatment Market Research Report 2024

Global Urinalysis Test Strips and Tablets Market Research Report 2024

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Chronic Kidney Disease Drugs Market Research Report 2025

Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diuretic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Diagnosis Market Research Report 2025

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Urinary Antispasodics Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-11M13290

Global Urinary Antispasodics Market Research Report 2024

FEATURED COMPANIES

Urinary Antispasodics Market Size

Urinary Antispasodics Market

Report Scope

Scope of Urinary Antispasodics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Urinary Antispasodics Market report?

What are the Application segmentation covered in the Urinary Antispasodics Market report?

What are the Type segmentation covered in the Urinary Antispasodics Market report?

Recommended Reports

Urinary & Renal Therapies

Antispasmodic & Related Drugs

Bladder & Prostate Treatments

FEATURED COMPANIES

RELATED REPORTS